TWIST1 and acute myeloid leukemia: Using European LeukemiaNet-defined AML risk grouping, we find that Twist1 overexpression is most commonly associated with good-risk patients (5/5, 100%), but it is less frequently seen in patients with poor molecular/cytogenetic risk (2/8, 25%).